Literature DB >> 33147428

The effect of COVID-19 public health measures on nationally notifiable diseases in Australia: preliminary analysis.

Amy Bright1, Anna-Jane Glynn-Robinson1, Stacey Kane1, Rose Wright1, Nathan Saul1.   

Abstract

ABSTRACT: Since the introduction of COVID-19-related public health measures, notifications for most nationally notifiable diseases have declined when compared to previous years. Physical distancing, travel restrictions, and emphasis on hygiene are likely to have affected the number of expected notifications, with the greatest reductions observed among disease spread via person-to-person contact such as influenza, and among overseas-acquired infections such as dengue virus and measles. However, quantifying the magnitude of the effect of COVID-19 public health measures on communicable diseases in Australia will be difficult, due to confounding factors such as: changes in testing priorities in laboratories; diversion of resources to the COVID-19 response; changes in health-seeking behaviours; greater utilisation of telehealth practices; and financial impacts such as income loss and ability to afford healthcare. It is considered likely that these other factors will have also impacted notification numbers. © Commonwealth of Australia CC BY-NC-ND.

Entities:  

Keywords:  Australia; COVID-19; communicable disease

Mesh:

Year:  2020        PMID: 33147428     DOI: 10.33321/cdi.2020.44.85

Source DB:  PubMed          Journal:  Commun Dis Intell (2018)        ISSN: 2209-6051


  8 in total

1.  Malaria time series in the extra-Amazon region of Brazil: epidemiological scenario and a two-year prediction model.

Authors:  Klauss Kleydmann Sabino Garcia; Amanda Amaral Abrahão; Ana Flávia de Morais Oliveira; Karina Medeiros de Deus Henriques; Anielle de Pina-Costa; André Machado Siqueira; Walter Massa Ramalho
Journal:  Malar J       Date:  2022-05-31       Impact factor: 3.469

Review 2.  Effects of COVID-19 Non-Pharmacological Interventions on Dengue Infection: A Systematic Review and Meta-Analysis.

Authors:  Qin Wu; Shuwen Dong; Xiaokang Li; Boyang Yi; Huan Hu; Zhongmin Guo; Jiahai Lu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-19       Impact factor: 6.073

3.  The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook.

Authors:  Cr Robert George; Robert Booy; Michael D Nissen; Monica M Lahra
Journal:  Med J Aust       Date:  2022-03-27       Impact factor: 12.776

4.  COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases.

Authors:  Shuilian Chen; Xixing Zhang; Yinzhu Zhou; Kewei Yang; Xin Lu
Journal:  J Infect       Date:  2021-04-22       Impact factor: 6.072

5.  Hospital costs of immunopreventable diseases in the economically active population in Brazil.

Authors:  Élide Sbardellotto M da Costa; Adriano Hyeda; Eliane M C P Maluf
Journal:  BMC Health Serv Res       Date:  2021-11-11       Impact factor: 2.655

Review 6.  COVID-19 in children: I. Epidemiology, prevention and indirect impacts.

Authors:  Annaleise R Howard-Jones; Asha C Bowen; Margie Danchin; Archana Koirala; Ketaki Sharma; Daniel K Yeoh; David P Burgner; Nigel W Crawford; Emma Goeman; Paul E Gray; Peter Hsu; Stephanie Kuek; Brendan J McMullan; Shidan Tosif; Danielle Wurzel; Philip N Britton
Journal:  J Paediatr Child Health       Date:  2021-10-13       Impact factor: 1.929

Review 7.  The impact of COVID-19 on public health systems in the Pacific Island Countries and Territories.

Authors:  Leila Bell; Caroline van Gemert; Onofre Edwin Merilles; Haley L Cash; Mark Stoové; Margaret Hellard
Journal:  Lancet Reg Health West Pac       Date:  2022-06-24

8.  Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study.

Authors:  Monica Tang; Benjamin Daniels; Maria Aslam; Andrea Schaffer; Sallie-Anne Pearson
Journal:  Lancet Reg Health West Pac       Date:  2021-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.